Top

Published in:

01-06-2018 | Original Contributions

Sleeve Gastrectomy after Renal Transplantation

Authors: Germán Viscido, Verónica Gorodner, Franco Jose Signorini, Mario Campazzo, Luciano Navarro, Lucio Ricardo Obeide, Federico Moser

Published in: Obesity Surgery | Issue 6/2018

Abstract

Background

Obesity induces or accelerates diabetes (DBT), hypertension (HT), and dyslipidemia (DSL), which are the main causes of renal failure. Obesity exacerbates in patients after renal transplantation (RT), and it has been associated with increased mortality rate, postoperative complications, and graft loss. We hypothesize that bariatric surgery might have a positive effect on obese patients with history of previous RT.

Methods

This was a retrospective review from prospectively collected data. Patients with sleeve gastrectomy (SG) with history of RT were studied. Demographics, anthropometric data, effect on comorbidities, postoperative course, immunosuppressive treatment, reason for transplantation, kidney function, graft survival, and quality of life associated with SG in obese patients with previous RT were assessed using a survey.

Results

From January 1, 2012 to January 1, 2016, five kidney transplant patients were operated on; 80% were female, with an average preoperative BMI of 42.18 ± 8.5 kg/m² (range 37–54). Related comorbidities: 100% of the patients had HT and DSL, whereas 40% had DBT and gout. The average time gap between RT and SG was 15 ± 8.4 years (range 3–22). Average operative time was 65 ± 12 min (range 60–85), and there were neither complications nor mortality. At 16.8 ± 14.5 months (range 5–46) of follow-up, BMI was 29.8 ± 7.3 kg/m² (range 26–44). All patients with HT and DSL were able to decrease their medication, showing improvement in blood pressure levels and laboratory test values. Regarding DBT, insulin was discontinued in one case, limiting the treatment to the use of oral hypoglycemic agents only. In another case, insulin dosage was significantly reduced. Graft function and proteinuria level improved in 80% of patients. All patients experienced a significant improvement in their quality of life.

Conclusion

In this specific group of high-risk patients, SG showed encouraging results in terms of weight loss and resolution/improvement of comorbidities, renal function, and quality of life.

Imes CC, Burke LE. The obesity epidemic: the United States as a cautionary tale for the rest of the world. Curr Epidemiol Rep. 2014;1(2):82–8. https://doi.org/10.1007/s40471-014-0012-6.CrossRefPubMedPubMedCentral

Wickman C, Kramer H. Obesity and kidney disease: potential mechanisms. Semin Nephrol. 2013;33(1):14–22. https://doi.org/10.1016/j.semnephrol.2012.12.006.CrossRefPubMed

Ejerblad E, Fored CM, Lindblad P, et al. Obesity and risk for chronic renal failure. J Am Soc Nephrol. 2006;17(6):1695–702. https://doi.org/10.1681/ASN.2005060638.CrossRefPubMed

Lysaght MJ. Maintenance dialysis population dynamics: current trends and long-term implications. J Am Soc Nephrol. 2002;13:S37–40.PubMed

Kramer HJ, Saranathan A, Luke A, et al. Increasing body mass index and obesity in the incident ESRD population. J Am Soc Nephrol. 2006;17(5):1453–9. https://doi.org/10.1681/ASN.2005111241.CrossRefPubMed

Friedman AN, Miskulin DC, Rosenberg IH, et al. Demographics and trends in overweight and obesity in patients at time of kidney transplantation. Am J Kidney Dis. 2003;41(2):480–7. https://doi.org/10.1053/ajkd.2003.50059.CrossRefPubMed

Kälble T, Lucan M, Nicita G, et al. EAU guidelines on renal transplantation. Eur Urol. 2005;47(2):156–66. https://doi.org/10.1016/j.eururo.2004.02.009.CrossRefPubMed

Dudley C, Harden P. Renal Association Clinical Practice Guideline on the assessment of the potential kidney transplant recipient. Nephron Clin Pract. 2011;118(Suppl 1):c209–24. https://doi.org/10.1159/000328070.CrossRefPubMed

MacLaughlin HL, Cook SA, Kariyawasam D, et al. Nonrandomized trial of weight loss with orlistat, nutrition education, diet, and exercise in obese patients with CKD: 2-year follow-up. Am J Kidney Dis. 2010;55(1):69–76. https://doi.org/10.1053/j.ajkd.2009.09.011.CrossRefPubMed

10.

Zrim S, Furlong T, Grace BS, et al. Body mass index and postoperative complications in kidney transplant recipients. Nephrology (Carlton). 2012;17(6):582–7. https://doi.org/10.1111/j.1440-1797.2012.01621.x.CrossRef

11.

Hricik DE. Metabolic syndrome in kidney transplantation: management of risk factors. Clin J Am Soc Nephrol. 2011;6(7):1781–5. https://doi.org/10.2215/CJN.01200211.CrossRefPubMed

12.

Thoma B, Grover VK, Shoker A. Prevalence of weight gain in patients with better renal transplant function. Clin Nephrol. 2006;65(06):408–14. https://doi.org/10.5414/CNP65408.CrossRefPubMed

13.

Chan W, Bosch JA, Jones D, et al. Obesity in kidney transplantation. J Ren Nutr. 2014;24(1):1–12. https://doi.org/10.1053/j.jrn.2013.09.002.CrossRefPubMed

14.

Pischon T, Sharma AM. Obesity as a risk factor in renal transplant patients. Nephrol Dial Transplant. 2001;16(1):14–7. https://doi.org/10.1093/ndt/16.1.14.CrossRefPubMed

15.

Patel MG. The effect of dietary intervention on weight gains after renal transplantation. J Ren Nutr. 1998;8(3):137–41. https://doi.org/10.1016/S1051-2276(98)90005-X.CrossRefPubMed

16.

Orazio LK, Isbel NM, Armstrong KA, et al. Evaluation of dietetic advice for modification of cardiovascular disease risk factors in renal transplant recipients. J Ren Nutr. 2011;21(6):462–71. https://doi.org/10.1053/j.jrn.2010.12.002.CrossRefPubMed

17.

Jezior D, Krajewska M, Madziarska K, et al. Weight reduction in renal transplant recipients program: the first successes. Transplant Proc. 2007;39(9):2769–71. https://doi.org/10.1016/j.transproceed.2007.08.055.CrossRefPubMed

18.

Maggard MA, Shugarman LR, Suttorp M, et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med. 2005;142(7):547–59. https://doi.org/10.7326/0003-4819-142-7-200504050-00013.CrossRefPubMed

19.

Colquitt JL, Pickett K, Loveman E, et al. Surgery for weight loss in adults. Cochrane Database Syst Rev. 2014;8:CD003641.

20.

Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004;240(3):416–23. https://doi.org/10.1097/01.sla.0000137343.63376.19.CrossRefPubMedPubMedCentral

21.

Szomstein S, Rojas R, Rosenthal RJ. Outcomes of laparoscopic bariatric surgery after renal transplant. Obes Surg. 2010;20(3):383–5. https://doi.org/10.1007/s11695-009-9969-5.CrossRefPubMed

22.

Alexander JW, Goodman HR, Gersin K, et al. Gastric bypass in morbidly obese patients with chronic renal failure and kidney transplant. Transplantation. 2004;78(3):469–74. https://doi.org/10.1097/01.TP.0000128858.84976.27.CrossRefPubMed

23.

Trastulli S, Desiderio J, Guarino S, et al. Laparoscopic sleeve gastrectomy compared with other bariatric surgical procedures: a systematic review of randomized trials. Surg Obes Relat Dis. 2013;9(5):816–29. https://doi.org/10.1016/j.soard.2013.05.007.CrossRefPubMed

24.

Hutter MM, Schirmer BD, Jones DB, et al. First report from the American College of Surgeons Bariatric Surgery Center Network: laparoscopic sleeve gastrectomy has morbidity and effectiveness positioned between the band and the bypass. Ann Surg. 2011;254(3):410–20. https://doi.org/10.1097/SLA.0b013e31822c9dac.CrossRefPubMedPubMedCentral

25.

Young MT, Gebhart A, Phelan MJ, et al. Use and outcomes of laparoscopic sleeve gastrectomy vs laparoscopic gastric bypass: analysis of the American College of Surgeons NSQIP. J Am Coll Surg. 2015;220(5):880–5. https://doi.org/10.1016/j.jamcollsurg.2015.01.059.CrossRefPubMed

26.

Arias E, Martínez PR, Ka Ming Li V, et al. Mid-term follow-up after sleeve gastrectomy as a final approach for morbid obesity. Obes Surg. 2009;19(5):544–8. https://doi.org/10.1007/s11695-009-9818-6.CrossRefPubMed

27.

Golomb I, Winkler J, Ben-Yakov A, et al. Laparoscopic sleeve gastrectomy as a weight reduction strategy in obese patients after kidney transplantation. Am J Transplant. 2014;14(10):2384–90. https://doi.org/10.1111/ajt.12829.CrossRefPubMed

28.

Elli EF, Gonzalez-Heredia R, Sanchez-Johnsen L, et al. Sleeve gastrectomy surgery in obese patients post-organ transplantation. Surg Obes Relat Dis. 2016;12(3):528–34. https://doi.org/10.1016/j.soard.2015.11.030.CrossRefPubMed

29.

Zelones J, Biswas O, Mehran A. Laparoscopic sleeve gastrectomy after simultaneous pancreas–kidney transplant. Am Surg. 2012;78(5):613–4.PubMed

30.

Oria HE, Moorehead MK. Updated bariatric analysis and reporting outcome system (BAROS). Surg Obes Relat Dis. 2009;5(1):60–6. https://doi.org/10.1016/j.soard.2008.10.004.CrossRefPubMed

31.

Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2014;384(9945):766–81. https://doi.org/10.1016/S0140-6736(14)60460-8.CrossRefPubMedPubMedCentral

32.

Wissing KM, Pipeleers L. Obesity, metabolic syndrome and diabetes mellitus after renal transplantation: prevention and treatment. Transplant Rev (Orlando). 2014;28(2):37–46. https://doi.org/10.1016/j.trre.2013.12.004.CrossRef

33.

Wiecek A, Kokot F, Chudek J, et al. The adipose tissue—a novel endocrine organ of interest to the nephrologist. Nephrol Dial Transplant. 2002;17(2):191–5. https://doi.org/10.1093/ndt/17.2.191.CrossRefPubMed

34.

Teplan V, Schück O, Stollová M, et al. Obesity and hyperhomocysteinaemia after kidney transplantation. Nephrol Dial Transplant. 2003;8(Suppl 5):v71–3.CrossRef

35.

Lin MY, Tavakol MM, Sarin A, et al. Laparoscopic sleeve gastrectomy is safe and efficacious for pretransplant candidates. Surg Obes Relat Dis. 2013;9(5):653–8. https://doi.org/10.1016/j.soard.2013.02.013.CrossRefPubMed

36.

Takata MC, Campos GM, Ciovica R, et al. Laparoscopic bariatric surgery improves candidacy in morbidly obese patients awaiting transplantation. Surg Obes Relat Dis. 2008;4(2):159–64. https://doi.org/10.1016/j.soard.2007.12.009.CrossRefPubMed

37.

Rogers CC, Alloway RR, Alexander JW, et al. Pharmacokinetics of mycophenolic acid, tacrolimus and sirolimus after gastric bypass surgery in end-stage renal disease and transplant patients: a pilot study. Clin Transpl. 2008;22:281–91.CrossRef

38.

Wesley Alexander J, Goodman H. Gastric bypass in chronic renal failure and renal transplant. Nutr Clin Pract. 2007;22(1):16–21. https://doi.org/10.1177/011542650702200116.CrossRefPubMed

39.

Al-Nowaylati AR, Al-Haddad BJ, Dorman RB, et al. Gastric bypass after liver transplantation. Liver Transpl. 2013;19(12):1324–9. https://doi.org/10.1002/lt.23734.CrossRefPubMed

40.

Padwal R, Brocks D, Sharma AM. A systematic review of drug absorption following bariatric surgery and its theoretical implications. Obes Rev. 2010;11(1):41–50. https://doi.org/10.1111/j.1467-789X.2009.00614.x.CrossRefPubMed

41.

Greenblatt HK, Greenblatt DJ. Altered drug disposition following bariatric surgery: a research challenge. Clin Pharmacokinet. 2015;54(6):573–9. https://doi.org/10.1007/s40262-015-0259-1.CrossRefPubMed

42.

ASMBS Clinical Issues Committee. Updated position statement on sleeve gastrectomy as a bariatric procedure. Surg Obes Relat Dis. 2012;8:e21–6.CrossRef

43.

Gumbs A, Gagner M, Dakin G, et al. Sleeve gastrectomy for morbid obesity. Obes Surg. 2007;17(7):962–9. https://doi.org/10.1007/s11695-007-9151-x.CrossRefPubMed

44.

Jakob T, Cal P, Deluca L, et al. Shorter than 24-h hospital stay for sleeve gastrectomy is safe and feasible. Surg Endosc. 2016;30(12):5596–600. https://doi.org/10.1007/s00464-016-4933-7.CrossRefPubMed

45.

Catheline JM, Fysekidis M, Dbouk R, et al. Weight loss after sleeve gastrectomy in super superobesity. J Obes. 2012;2012:959260.CrossRefPubMedPubMedCentral

46.

Eisenberg D, Bellatorre A, Bellatorre N. Sleeve gastrectomy as a stand-alone bariatric operation for severe, morbid, and super obesity. JSLS. 2013;17(1):63–7. https://doi.org/10.4293/108680812X13517013317077.CrossRefPubMedPubMedCentral

47.

Lin MY, Tavakol MM, Sarin A, et al. Safety and feasibility of sleeve gastrectomy in morbidly obese patients following liver transplantation. Surg Endosc. 2013;27(1):81–5. https://doi.org/10.1007/s00464-012-2410-5.CrossRefPubMed

48.

Khoraki J, Katz MG, Funk LM, et al. Feasibility and outcomes of laparoscopic sleeve gastrectomy after solid organ transplantation. Surg Obes Relat Dis. 2016;12(1):75–83. https://doi.org/10.1016/j.soard.2015.04.002.CrossRefPubMed

49.

Shi X, Karmali S, Sharma AM, et al. A review of laparoscopic sleeve gastrectomy for morbid obesity. Obes Surg. 2010;20(8):1171–7. https://doi.org/10.1007/s11695-010-0145-8.CrossRefPubMed

50.

Robert M, Ferrand-Gaillard C, Disse E, et al. Predictive factors of type 2 diabetes remission 1 year after bariatric surgery: impact of surgical techniques. Obes Surg. 2013;23(6):770–5. https://doi.org/10.1007/s11695-013-0868-4.CrossRefPubMed

51.

Ziemiański P, Lisik W, Marszałek RJ, et al. Improvement of graft function following roux-en-Y gastric bypass surgery in a morbidly obese kidney recipient: a case report and literature review. Ann Transplant. 2014;19:639–42. https://doi.org/10.12659/AOT.892954.CrossRefPubMed

52.

Navarro-Díaz M, Serra A, Romero R, et al. Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up. J Am Soc Nephrol. 2006;17(12_suppl_3):S213–7. https://doi.org/10.1681/ASN.2006080917.CrossRefPubMed

53.

Fernández-Fresnedo G, Plaza JJ, Sánchez-Plumed J, et al. Proteinuria: a new marker of long-term graft and patient survival in kidney transplantation. Nephrol Dial Transplant. 2004;19(Suppl 3):iii47–51.PubMed

Title: Sleeve Gastrectomy after Renal Transplantation
Authors: Germán Viscido
Verónica Gorodner
Franco Jose Signorini
Mario Campazzo
Luciano Navarro
Lucio Ricardo Obeide
Federico Moser
Publication date: 01-06-2018
Publisher: Springer US
Published in: Obesity Surgery / Issue 6/2018
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI: https://doi.org/10.1007/s11695-017-3056-0

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Sleeve Gastrectomy after Renal Transplantation

Abstract

Background

Methods

Results

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 6/2018

Effects of Sleeve Gastrectomy on Nonalcoholic Fatty Liver Disease in an Obese Rat Model

Correction to: Age-Related Effects of Bariatric Surgery on Early Atherosclerosis and Cardiovascular Risk Reduction

A Dutch Nationwide Bariatric Quality Registry: DATO

Comparative Effectiveness of Laparoscopic Sleeve Gastrectomy on Morbidly Obese, Super-Obese, and Super-Super Obese Patients for the Treatment of Morbid Obesity

Correction to: Recommendations from Two Citizens’ Juries on the Surgical Management of Obesity

Metabolic Changes Up to 10 years After Gastric Bypass